Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2009
09/03/2009US20090221507 administering peptide sequence tyr-ser-met-lys-lys-thr-thr-met-lys-ile-ile-pro-phe-asn-arg-leu-thr-ile-gly to a mammal to treat degenerative disorder of the nervous system involves leakage of fibrinogen perivascularly in the brain; multiple sclerosis, spinal cord injury, stroke and Alzheimer's Disease
09/03/2009US20090221492 Expression of active human factor ix in mammary tissue of transgenic animals
09/03/2009US20090221483 Antimicrobial Cathelicidin Peptides
09/03/2009US20090221482 Tissue protective peptides and uses thereof
09/03/2009US20090221479 Lgi, lingo and p75ntr family members: novel modulators of neuronal growth
09/03/2009US20090221478 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
09/03/2009US20090221477 Linkers
09/03/2009US20090221476 Peptide Capable of Altering Tubulin Polymerization and use Thereof for Inhibiting Cell Proliferation
09/03/2009US20090221473 Antitumor agents
09/03/2009US20090221444 Method for Identifying, Marking and Treating Epithelial Lung Tumour Cells and Means for Carrying Out Said Method
09/03/2009US20090221440 Methods and compositions related to identifying protein-protein interactions
09/03/2009US20090221434 Use of particulate labels in bioanalyte detection methods
09/03/2009US20090221077 Process for producing cytotoxic lymphocytes
09/03/2009US20090221076 Method of fabricating sheet for cartilage tissue regeneration
09/03/2009US20090221075 System And Process For Separating A Material
09/03/2009US20090221074 Conductive polymer matrix and device for use in the efficient isolation of preferential stem cells; permits the monitoring of cell binding to the solid matrix during the selection process, it is possible to obtain feedback information on the number of selected cells at any time
09/03/2009US20090221073 Devices and methods for cell manipulation
09/03/2009US20090221072 Compositions and methods for modulating cell differentiation
09/03/2009US20090221071 Polyurea Systems, Processes for Preparing the Same and Use Thereof for Postoperative Adhesion Barriers
09/03/2009US20090221070 In Vitro Production of a Cell Population Using Feeder Cells
09/03/2009US20090221069 Method for augmenting the ability of t-cells and other cells for fighting disease and invade diseased organs, for elevating cd3 zeta and tnf-alpha expression in t-cells, and mixing t-cell boosting and kit particularly useful in such method
09/03/2009US20090221068 Cell Cultivation Method and Cell Culture
09/03/2009US20090221067 Cell lines that express hetero oligomeric taste receptors
09/03/2009US20090221066 Anti-Methylated Dna Antibody and Method for Production Thereof
09/03/2009US20090221040 immunizing an animal with a mixture of different histidine fusion polypeptides and obtaining polyclonal antibodies directed against the histidine portion of the fusion polypeptides from the serum of the animal; rapid
09/03/2009US20090221036 Recombinant anti-cd4 antibodies for human therapy
09/03/2009US20090221035 Systems and methods for protein production
09/03/2009US20090221034 Lipolytic Enzyme Variant With Improved Stability And Polynucleotides Encoding Same
09/03/2009US20090221033 Polypeptides Having Lipase Activity And Polynucleotides Encoding Same
09/03/2009US20090221032 Entropic bristle domain sequences and their use in recombinant protein production
09/03/2009US20090221029 Pfu replication accessory factors and methods of use
09/03/2009US20090221022 Three Dimensional Cell Culture
09/03/2009US20090221016 Modified tumor necrosis factor-alpha converting enzyme and methods of use thereof
09/03/2009US20090221003 Procedure for the generation of a high producer cell line for the expression of a recombinant anti-cd34 antibody
09/03/2009US20090220999 Antibodies immunoreactive with mutant 5-enolpyruvlshikimate-3-phosphate synthase
09/03/2009US20090220991 Reagents for the detection of protein phosphorylation in leukemia signaling pathways
09/03/2009US20090220979 Methods and Apparatus for Magnetic Separation of Cells
09/03/2009US20090220977 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
09/03/2009US20090220964 Methods for diagnosing and treating cancers via manipulations of a...pathway
09/03/2009US20090220960 Luciferase gene optimized for use in imaging of intracellular luminescence
09/03/2009US20090220959 Markers of definitive endoderm
09/03/2009US20090220933 Detection of fetal cells from maternal blood
09/03/2009US20090220670 Promoter-based silencing
09/03/2009US20090220605 Bone matrix compositions having nanoscale textured surfaces
09/03/2009US20090220595 Combination of erythropoietin glycoisoforms
09/03/2009US20090220569 Prevascularized Constructs for Implantation to Provide Blood Perfusion
09/03/2009US20090220567 Pure Populations of Astrocyte Restricted Precursor Cells and Methods for Isolation and Use Thereof
09/03/2009US20090220565 Method for producing autonomously contracting cardiac muscle cells from adult stem cells, in particular human adult stem cells
09/03/2009US20090220562 Osteogenic and anti-adipogenic oxysterols
09/03/2009US20090220561 Compositions comprising nanostructures for cell, tissue and artificial organ growth, and methods for making and using same
09/03/2009US20090220537 Vaccine delivery system
09/03/2009US20090220534 Methods for identifying t-cell epitopes associated with impaired peptide processing and applications of the identified epitopes
09/03/2009US20090220528 Stimulation of Toll-Like Receptors on T Cells
09/03/2009US20090220527 Affinity optimized epha2 agonistic antibodies and methods of use thereof
09/03/2009US20090220521 Anti MIF Antibodies
09/03/2009US20090220514 ADAM10 and its Uses Related to Infection
09/03/2009US20090220511 human polypeptides named IFN (interferon)- lambda 1, IFN- lambda 2 and IFN- lambda 3 and IFN- lambda R1; antiviral agents
09/03/2009US20090220510 Recognize aberrant glycosylated form of the EGFR; evident upon aberrant post-translational modification; cancer
09/03/2009US20090220504 Combinatorial therapy
09/03/2009US20090220491 Binding agents which inhibit myostatin
09/03/2009US20090220490 Compositions and Assays for Inhibiting HCV Infection
09/03/2009US20090220484 Rage/Diaphanous Interaction and Related Compositions and Methods
09/03/2009US20090220480 Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them
09/03/2009US20090220479 Egln2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart disease
09/03/2009US20090220476 Laglidadg homing endonuclease variants having mutations in two functional subdomains and use thereof
09/03/2009US20090220474 Novel a-galactosidases
09/03/2009US20090220473 Adir related polymorphisms and applications thereof
09/03/2009US20090220472 Method for Treating Malignant Melanoma
09/03/2009US20090220469 Peptides against autoantibodies associated with glaucoma and use of these peptides
09/03/2009US20090220468 Specific CD4+CD25+ Regulatory T Cells for Haematopoietic Cell Transplantation and Immune Tolerance
09/03/2009US20090220467 Use of type ii pneumocytes in the treatment of pulmonary diseases associated with pulmonary fibrosis
09/03/2009US20090220466 Very small embryonic-like (vsel) stem cells and methods of isolating and using the same
09/03/2009US20090220465 Methods and compositions for modulation of stem cell aging
09/03/2009US20090220464 Mesenchymal stem cells and uses therefor
09/03/2009US20090220462 Stem cells
09/03/2009US20090220458 Pseudotyped retroviral vectors and methods of use thereof
09/03/2009US20090220424 Pro104 Antibody Compositions and Methods of Use
09/03/2009CA2717086A1 Mutant gene that regulates oil-and-fat content in seed and method for regulating oil-and-fat content in seed
09/03/2009CA2717083A1 Methods of applying physical stimuli to cells
09/03/2009CA2716609A1 Stem cell expression cassettes
09/02/2009EP2096172A2 Genetic sequences having methyltransferase activity and uses therefor
09/02/2009EP2096169A1 Nuclear reprogramming method
09/02/2009EP2096166A1 Method for production of antibody directed against cell membrane surface antigen epitope and assaying method
09/02/2009EP2096122A1 Anti-human dlk-1 antibody showing anti-tumor activity in vivo
09/02/2009EP2095827A1 High affinity human monoclonal antibodies specific for RSV F-protein
09/02/2009EP2095823A1 GM-CSF for treating demyelination
09/02/2009EP2095127A1 Methods for screening and treatment involving the genes gypc, agpat3, agl, pvrl2, hmgb 3, hsdl2 and/or ldb2
09/02/2009EP2094839A1 Expansion of hematopoietic stem cells
09/02/2009EP2094838A1 Methods and compositions for differential expansion of fetal cells in maternal blood and their use
09/02/2009EP2094837A2 Use of pi3k m-tor and akt inhibitors to induce foxp3 expression and generate regulatory t cells
09/02/2009EP2094836A2 Generation of inner ear cells
09/02/2009EP2094835A1 Pluripotent cell growth media
09/02/2009EP2094834A2 Pluripotent cells from the mammalian late epiblast layer
09/02/2009EP2094833A2 Differentiation of pluripotent cells into primary germ layer progenitors
09/02/2009EP2094307A2 Tes7 and antibodies that bind thereto
09/02/2009EP2021463A4 Culture method for obtaining a clonal population of antigen-specific b cells
09/02/2009EP1983819A4 Nitrogen-efficient monocot plants
09/02/2009EP1931766A4 Method of culturing conifer somatic embryos using s(+)-abscisic acid
09/02/2009EP1910516A4 Suspension culture of human embryonic stem cells
09/02/2009EP1558278B1 Production of homotrimeric fusion proteins